CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 36.54
+5.44 (17.49%)
Sep 30, 2026, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 18.58 billion as of October 1, 2026. Its market cap has increased by 15.44% in one year.
Market Cap
18.58B
Enterprise Value
17.58B
Revenue
1.43B
Ranking
n/a
PE Ratio
192.41
Stock Price
36.54
ChartMarket Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 18.58B, an increase of 145.40%. That is a compound annual growth rate of 12.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 18.58B | 47.09% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 28.87B |
| China Resources Pharmaceutical Group | 27.36B |
| China Medical System Holdings | 25.50B |
| Sunshine Lake Pharma | 23.45B |
| Grand Pharmaceutical Group | 16.95B |
| The United Laboratories International Holdings | 15.32B |
| Fujian Haixi Pharmaceuticals | 13.03B |
| Consun Pharmaceutical Group | 12.21B |